Triple
T23030450
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Saccharomycotina |
E573440
|
entity |
| Predicate | includes |
P1393
|
FINISHED |
| Object | Candida dubliniensis |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Candida dubliniensis | Statement: [Saccharomycotina, includes, Candida dubliniensis]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Candida dubliniensis Context triple: [Saccharomycotina, includes, Candida dubliniensis]
-
A.
Candida tropicalis
Candida tropicalis is a species of opportunistic pathogenic yeast that commonly causes infections in immunocompromised individuals, particularly in hospital settings.
-
B.
Candida glabrata
Candida glabrata is an opportunistic pathogenic yeast species in humans, notable for causing bloodstream and mucosal infections and for its frequent resistance to azole antifungal drugs.
-
C.
Candida krusei
Candida krusei is an opportunistic pathogenic yeast species notable for causing invasive candidiasis and exhibiting intrinsic resistance to the antifungal drug fluconazole.
-
D.
Candida parapsilosis
Candida parapsilosis is an opportunistic yeast pathogen that commonly causes bloodstream and device-associated infections in humans, particularly in hospitalized and immunocompromised patients.
-
E.
Candida albicans
Candida albicans is a common opportunistic fungal pathogen in humans, often part of the normal microbiota but capable of causing infections ranging from superficial thrush to life-threatening systemic disease.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Candida dubliniensis Target entity description: Candida dubliniensis is a yeast-like fungal species closely related to Candida albicans, known for causing opportunistic infections particularly in immunocompromised individuals.
-
A.
Candida tropicalis
Candida tropicalis is a species of opportunistic pathogenic yeast that commonly causes infections in immunocompromised individuals, particularly in hospital settings.
-
B.
Candida glabrata
Candida glabrata is an opportunistic pathogenic yeast species in humans, notable for causing bloodstream and mucosal infections and for its frequent resistance to azole antifungal drugs.
-
C.
Candida krusei
Candida krusei is an opportunistic pathogenic yeast species notable for causing invasive candidiasis and exhibiting intrinsic resistance to the antifungal drug fluconazole.
-
D.
Candida parapsilosis
Candida parapsilosis is an opportunistic yeast pathogen that commonly causes bloodstream and device-associated infections in humans, particularly in hospitalized and immunocompromised patients.
-
E.
Candida albicans
Candida albicans is a common opportunistic fungal pathogen in humans, often part of the normal microbiota but capable of causing infections ranging from superficial thrush to life-threatening systemic disease.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e245b911188190bc3d96326c847969 |
completed | April 17, 2026, 2:37 p.m. |
| NER | Named-entity recognition | batch_69f18481072c81909ab2a2c87e034433 |
completed | April 29, 2026, 4:09 a.m. |
Created at: April 17, 2026, 3:53 p.m.